Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Hue Tu Quach, Zhaohua Hou, Rebecca Y. Bellis, Jasmeen K. Saini, Alfredo Amador-Molina, Prasad S. Adusumilli & Yuquan Xiong. (2022) Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1. Expert Opinion on Investigational Drugs 31:11, pages 1187-1202.
Read now
Read now
Jessica Pahle & Wolfgang Walther. (2016) Vectors and strategies for nonviral cancer gene therapy. Expert Opinion on Biological Therapy 16:4, pages 443-461.
Read now
Read now
Derek A Wainwright, Pragati Nigam, Bart Thaci, Mahua Dey & Maciej S Lesniak. (2012) Recent developments on immunotherapy for brain cancer. Expert Opinion on Emerging Drugs 17:2, pages 181-202.
Read now
Read now
Lukas J. A. C. Hawinkels & Peter ten Dijke. (2011) Exploring anti-TGF-β therapies in cancer and fibrosis. Growth Factors 29:4, pages 140-152.
Read now
Read now
Kaveh Asadi-Moghaddam, E Antonio Chiocca & Sean E Lawler. (2010) Potential role of miRNAs and their inhibitors in glioma treatment. Expert Review of Anticancer Therapy 10:11, pages 1753-1762.
Read now
Read now
Articles from other publishers (35)
Liqun Tu, Zhe Wang, Lei Yang, Xiaomeng Sun, Yunpeng Yao, Peng Zhang, Xiaotian Zhang, Liying Wang, Yongli Yu & Ming Yang. (2023) Incorporation of a TGF-β2-inhibiting oligodeoxynucleotide molecular adjuvant into a tumor cell lysate vaccine to enhance antiglioma immunity in mice. Frontiers in Immunology 14.
Crossref
Crossref
Juan Wang, Zhonghang Xu, Zhe Wang, Guoqiang Du & Limin Lun. (2021) TGF-beta signaling in cancer radiotherapy. Cytokine 148, pages 155709.
Crossref
Crossref
Byung-Gyu Kim, Ehsan Malek, Sung Hee Choi, James J. Ignatz-Hoover & James J. Driscoll. (2021) Novel therapies emerging in oncology to target the TGF-β pathway. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Bin Ji, Lijuan Liu, Yongping Guo, Feng Ming, Jun Jiang, Fangfang Li, Guo’an Zhao, Jianyong Wen & Ning Li. (2021) Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter. Computational and Mathematical Methods in Medicine 2021, pages 1-8.
Crossref
Crossref
Haoyu Xiong, Rakesh N. Veedu & Sarah D. Diermeier. (2021) Recent Advances in Oligonucleotide Therapeutics in Oncology. International Journal of Molecular Sciences 22:7, pages 3295.
Crossref
Crossref
Anne-Ulrike Trendelenburg. 2020. Anti-fibrotic Drug Discovery. Anti-fibrotic Drug Discovery
1
36
.
Alexandros Papachristodoulou, Manuela Silginer, Michael Weller, Hannah Schneider, Kathy Hasenbach, Michel Janicot & Patrick Roth. (2019) Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas. Clinical Cancer Research 25:23, pages 7189-7201.
Crossref
Crossref
Fatih M. Uckun, Sanjive Qazi, Larn Hwang & Vuong N. Trieu. (2019) Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up. Cancers 11:12, pages 1892.
Crossref
Crossref
Jialong Jie, Ye Xia, Chun-Hua Huang, Hongmei Zhao, Chunfan Yang, Kunhui Liu, Di Song, Ben-Zhan Zhu & Hongmei Su. (2019) Sulfur-centered hemi-bond radicals as active intermediates in S-DNA phosphorothioate oxidation. Nucleic Acids Research.
Crossref
Crossref
Rosemary J. Akhurst. (2017) Targeting TGF-β Signaling for Therapeutic Gain. Cold Spring Harbor Perspectives in Biology 9:10, pages a022301.
Crossref
Crossref
Jian Wang, Hoi-Kei Lon, Shwu-Luan Lee, Gilbert J. Burckart & David S. Pisetsky. (2015) Oligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and Immunogenicity. Therapeutic Innovation & Regulatory Science 49:6, pages 861-868.
Crossref
Crossref
Krishnamurthy Thyagarajan, Shilpak Chatterjee, Pravin Kesarwani, Michael I. Nishimura & Shikhar Mehrotra. 2015. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Resistance of Cancer Cells to CTL-Mediated Immunotherapy
303
349
.
Annabelle Trojan, Lina M. Jay, Heliodor Kasprzak, Donald D. Anthony & Jerzy Trojan. (2014) Immunotherapy of Malignant Tumors Using Antisense Anti-IGF-I Approach: Case of Glioblastoma. Journal of Cancer Therapy 05:07, pages 685-705.
Crossref
Crossref
Dong-Sup Chung, Hye-Jin Shin & Yong-Kil Hong. (2014) A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy. Journal of Immunology Research 2014, pages 1-16.
Crossref
Crossref
Markus J. Riemenschneider, David N. Louis, Michael Weller & Peter Hau. (2013) Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach. Acta Neuropathologica 126:1, pages 21-37.
Crossref
Crossref
Prachi Agarwala, Satyaprakash Pandey, Koyeli Mapa & Souvik Maiti. (2013) The G-Quadruplex Augments Translation in the 5′ Untranslated Region of Transforming Growth Factor β2. Biochemistry 52:9, pages 1528-1538.
Crossref
Crossref
Kerstin Krieglstein. 2013. TGF-β in Human Disease. TGF-β in Human Disease
391
412
.
Jing Wan, John A. Bauman, Maria Anna Graziewicz, Peter Sazani & Ryszard Kole. 2013. RNA and Cancer. RNA and Cancer
213
233
.
Dana Faingold, Silvin Bakalian & Dawn S. Russell-Hermanns. 2013. Experimental and Clinical Metastasis. Experimental and Clinical Metastasis
445
469
.
H. L. Lightfoot & J. Hall. (2012) Target mRNA inhibition by oligonucleotide drugs in man. Nucleic Acids Research 40:21, pages 10585-10595.
Crossref
Crossref
Anna L. Smith, Tyler P. Robin & Heide L. Ford. (2012) Molecular Pathways: Targeting the TGF-β Pathway for Cancer Therapy. Clinical Cancer Research 18:17, pages 4514-4521.
Crossref
Crossref
Henriett Butz, Károly Rácz, László Hunyady & Attila Patócs. (2012) Crosstalk between TGF-β signaling and the microRNA machinery. Trends in Pharmacological Sciences 33:7, pages 382-393.
Crossref
Crossref
Lianming Wu, David E. White, Connie Ye, Frederick G. Vogt, Gerald J. Terfloth & Hayao Matsuhashi. (2012) Desulfurization of phosphorothioate oligonucleotides via the sulfur-by-oxygen replacement induced by the hydroxyl radical during negative electrospray ionization mass spectrometry. Journal of Mass Spectrometry 47:7, pages 836-844.
Crossref
Crossref
S. Catuogno, C. L. Esposito, C. Quintavalle, G. Condorelli, V. de Franciscis & L. Cerchia. (2012) Nucleic Acids in Human Glioma Treatment: Innovative Approaches and Recent Results. Journal of Signal Transduction 2012, pages 1-11.
Crossref
Crossref
Omar E. Franco & Simon W. Hayward. 2012. Current Challenges in Personalized Cancer Medicine. Current Challenges in Personalized Cancer Medicine
267
313
.
Eric P. Hoffman, Abby Bronson, Arthur A. Levin, Shin'ichi Takeda, Toshifumi Yokota, Andreas R. Baudy & Edward M. Connor. (2011) Restoring Dystrophin Expression in Duchenne Muscular Dystrophy Muscle. The American Journal of Pathology 179:1, pages 12-22.
Crossref
Crossref
C Huynh, M F Segura, A Gaziel-Sovran, S Menendez, F Darvishian, L Chiriboga, B Levin, D Meruelo, I Osman, J Zavadil, E G Marcusson & E Hernando. (2010) Efficient in vivo microRNA targeting of liver metastasis. Oncogene 30:12, pages 1481-1488.
Crossref
Crossref
Trina J. Stewart & Mark J. Smyth. (2011) Improving cancer immunotherapy by targeting tumor-induced immune suppression. Cancer and Metastasis Reviews 30:1, pages 125-140.
Crossref
Crossref
Dinah W.Y. Sah & Neil Aronin. (2011) Oligonucleotide therapeutic approaches for Huntington disease. Journal of Clinical Investigation 121:2, pages 500-507.
Crossref
Crossref
Hilko Ardon, Steven De Vleeschouwer, Frank Van Calenbergh & Stefaan W. Van Gool. 2011. Tumors of the Central Nervous System, Volume 2. Tumors of the Central Nervous System, Volume 2
313
333
.
Pierre-Yves Dietrich, Valérie Dutoit, Nhu Nam Tran Thang & Paul R Walker. (2010) T-cell immunotherapy for malignant glioma: toward a combined approach. Current Opinion in Oncology 22:6, pages 604-610.
Crossref
Crossref
Leopold Arko, Igor Katsyv, Grace E. Park, William Patrick Luan & John K. Park. (2010) Experimental approaches for the treatment of malignant gliomas. Pharmacology & Therapeutics 128:1, pages 1-36.
Crossref
Crossref
Shiyue Fang & Suntara Fueangfung. (2010) Scalable Synthetic Oligodeoxynucleotide Purification with Use of a Catching by Polymerization, Washing, and Releasing Approach. Organic Letters 12:16, pages 3720-3723.
Crossref
Crossref
M. Westphal & W. Stummer. (2010) Lokale Therapien bei hirneigenen TumorenLocal therapy of primary brain tumors. Der Nervenarzt 81:8, pages 913-917.
Crossref
Crossref
Andrei V. Chernov, Svetlana Baranovskaya, Vladislav S. Golubkov, Dustin R. Wakeman, Evan Y. Snyder, Roy Williams & Alex Y. Strongin. (2010) Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in Cancer. Journal of Biological Chemistry 285:25, pages 19647-19659.
Crossref
Crossref